JP2002501030A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002501030A5 JP2002501030A5 JP2000528296A JP2000528296A JP2002501030A5 JP 2002501030 A5 JP2002501030 A5 JP 2002501030A5 JP 2000528296 A JP2000528296 A JP 2000528296A JP 2000528296 A JP2000528296 A JP 2000528296A JP 2002501030 A5 JP2002501030 A5 JP 2002501030A5
- Authority
- JP
- Japan
- Prior art keywords
- product
- tissue
- solvent
- product according
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000047 product Substances 0.000 description 65
- 210000001519 tissue Anatomy 0.000 description 45
- 239000002904 solvent Substances 0.000 description 31
- 238000000034 method Methods 0.000 description 27
- 241000251511 Holothuroidea Species 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 16
- 239000000284 extract Substances 0.000 description 15
- 150000002632 lipids Chemical class 0.000 description 12
- 239000003463 adsorbent Substances 0.000 description 10
- 241000124008 Mammalia Species 0.000 description 9
- 201000004681 Psoriasis Diseases 0.000 description 9
- 239000003921 oil Substances 0.000 description 8
- 239000003963 antioxidant agent Substances 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 235000006708 antioxidants Nutrition 0.000 description 7
- 238000001035 drying Methods 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- 102000001381 Arachidonate 5-Lipoxygenase Human genes 0.000 description 4
- 108010093579 Arachidonate 5-lipoxygenase Proteins 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 229920001287 Chondroitin sulfate Polymers 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000033115 angiogenesis Effects 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 229940059329 chondroitin sulfate Drugs 0.000 description 4
- 239000004927 clay Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 102000011730 Arachidonate 12-Lipoxygenase Human genes 0.000 description 3
- 108010076676 Arachidonate 12-lipoxygenase Proteins 0.000 description 3
- 240000007551 Boswellia serrata Species 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 102000003820 Lipoxygenases Human genes 0.000 description 3
- 108090000128 Lipoxygenases Proteins 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 235000021466 carotenoid Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002594 sorbent Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- 229940124073 Complement inhibitor Drugs 0.000 description 2
- 206010012438 Dermatitis atopic Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 206010003246 arthritis Diseases 0.000 description 2
- 201000008937 atopic dermatitis Diseases 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000003610 charcoal Substances 0.000 description 2
- 230000024203 complement activation Effects 0.000 description 2
- 239000004074 complement inhibitor Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229940094952 green tea extract Drugs 0.000 description 2
- 235000020688 green tea extract Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 239000001294 propane Substances 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- KGIJOOYOSFUGPC-CABOLEKPSA-N 5-HETE Natural products CCCCC\C=C/C\C=C/C\C=C/C=C/[C@H](O)CCCC(O)=O KGIJOOYOSFUGPC-CABOLEKPSA-N 0.000 description 1
- KGIJOOYOSFUGPC-MSFIICATSA-N 5-Hydroxyeicosatetraenoic acid Chemical compound CCCCCC=CCC=CCC=C\C=C\[C@@H](O)CCCC(O)=O KGIJOOYOSFUGPC-MSFIICATSA-N 0.000 description 1
- VNYSSYRCGWBHLG-UKNWISKWSA-N 6-trans-leukotriene B4 Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C\[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-UKNWISKWSA-N 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 description 1
- 102000009515 Arachidonate 15-Lipoxygenase Human genes 0.000 description 1
- 108010048907 Arachidonate 15-lipoxygenase Proteins 0.000 description 1
- 235000018062 Boswellia Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- VNYSSYRCGWBHLG-CTOJTRLNSA-N Delta(6)-trans-12-epi-leukotriene B4 Chemical compound CCCCC\C=C/C[C@H](O)\C=C\C=C\C=C\[C@@H](O)CCCC(O)=O VNYSSYRCGWBHLG-CTOJTRLNSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 239000000867 Lipoxygenase Inhibitor Substances 0.000 description 1
- 229940122142 Lipoxygenase inhibitor Drugs 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 description 1
- 206010029113 Neovascularisation Diseases 0.000 description 1
- HKEUNPBPUZYDBD-IBGZPJMESA-N O[C@H](C(=O)O)CCCC=CC=C/CC=C/CC=C/CCCCC Chemical compound O[C@H](C(=O)O)CCCC=CC=C/CC=C/CC=C/CCCCC HKEUNPBPUZYDBD-IBGZPJMESA-N 0.000 description 1
- 229940122060 Ornithine decarboxylase inhibitor Drugs 0.000 description 1
- 102000052812 Ornithine decarboxylases Human genes 0.000 description 1
- 108700005126 Ornithine decarboxylases Proteins 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940121369 angiogenesis inhibitor Drugs 0.000 description 1
- 239000004037 angiogenesis inhibitor Substances 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 238000011394 anticancer treatment Methods 0.000 description 1
- 229940030999 antipsoriatics Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003637 basic solution Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000001895 carotenoid group Chemical group 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 239000010776 emu oil Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940002508 ginger extract Drugs 0.000 description 1
- 235000020708 ginger extract Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 208000024798 heartburn Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- VNYSSYRCGWBHLG-AMOLWHMGSA-M leukotriene B4(1-) Chemical compound CCCCC\C=C/C[C@@H](O)\C=C\C=C\C=C/[C@@H](O)CCCC([O-])=O VNYSSYRCGWBHLG-AMOLWHMGSA-M 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000002818 ornithine decarboxylase inhibitor Substances 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001185 psoriatic effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 125000005624 silicic acid group Chemical group 0.000 description 1
- 229960004245 silymarin Drugs 0.000 description 1
- 235000017700 silymarin Nutrition 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 229940100615 topical ointment Drugs 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000010681 turmeric oil Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/010,123 | 1998-01-21 | ||
| US09/010,123 US6055936A (en) | 1997-01-21 | 1998-01-21 | Sea cucumber carotenoid lipid fractions and process |
| PCT/US1999/001179 WO1999037314A1 (en) | 1998-01-21 | 1999-01-20 | Sea cucumber carotenoid lipid fraction products and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002501030A JP2002501030A (ja) | 2002-01-15 |
| JP2002501030A5 true JP2002501030A5 (enExample) | 2006-03-09 |
Family
ID=21744015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000528296A Pending JP2002501030A (ja) | 1998-01-21 | 1999-01-20 | ナマコカロテノイド脂質画分産物およびその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US6055936A (enExample) |
| EP (1) | EP1047437A4 (enExample) |
| JP (1) | JP2002501030A (enExample) |
| KR (1) | KR100573423B1 (enExample) |
| CN (1) | CN1247205C (enExample) |
| AU (1) | AU737567B2 (enExample) |
| BR (1) | BR9907189A (enExample) |
| CA (1) | CA2319093C (enExample) |
| IL (1) | IL137293A0 (enExample) |
| IS (1) | IS5566A (enExample) |
| NO (1) | NO327883B1 (enExample) |
| NZ (1) | NZ506420A (enExample) |
| RU (1) | RU2234928C2 (enExample) |
| WO (1) | WO1999037314A1 (enExample) |
Families Citing this family (51)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2251265A1 (en) * | 1998-10-21 | 2000-04-21 | Universite De Sherbrooke | Process for lipid extraction of aquatic animal tissues producing a dehydrated residue |
| US6399105B1 (en) * | 1999-01-20 | 2002-06-04 | Peter Donald Collin | Sea cucumber carotenoid lipid fraction products and methods of use |
| NO309730B1 (no) * | 1999-06-09 | 2001-03-19 | Terje Stroem | Fremgangsmåte ved ekstraksjon av lipid fra biologisk materiale |
| GB2358862B (en) * | 1999-12-21 | 2004-07-21 | Fermentron Ltd | Processes for Extracting Carotenoids from Biomass Carotenoid Sources |
| CA2305091C (en) * | 2000-04-12 | 2002-10-22 | Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food | Separation of carotenoids from fruits and vegetables |
| RU2183962C2 (ru) * | 2000-05-25 | 2002-06-27 | Долматова Людмила Степановна | Композиция для лечения и профилактики кожных заболеваний и ран у человека и животных |
| KR100405958B1 (ko) * | 2000-12-07 | 2003-11-15 | 한국식품개발연구원 | 갑각류 또는 키틴 제조부산물로부터 색소를 분리하는 방법및 이를 주원료로 하는 어류 또는 산란계용 착색제 조성물 |
| US6916492B2 (en) * | 2001-03-30 | 2005-07-12 | Council Of Scientific & Industrial Research | Natural nontoxic multicolor fluorescent protein dye from a marine invertebrate, compositions containing the said dye and its uses |
| JP2004517172A (ja) * | 2001-03-30 | 2004-06-10 | カウンシル・オブ・サイエンティフィック・アンド・インダストリアル・リサーチ | 海洋無脊椎動物から得た天然蛍光色素、前記色素を含む組成物類、およびそれらの用途 |
| US6689391B2 (en) * | 2001-03-30 | 2004-02-10 | Council Of Scientific & Industrial Research | Natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses |
| WO2002079327A1 (en) * | 2001-03-30 | 2002-10-10 | Council Of Scientific And Industrial Research | A natural fluorescent dye obtained from a marine invertebrate, compositions containing the said dye and their uses |
| US6387416B1 (en) * | 2001-04-05 | 2002-05-14 | Thomas Newmark | Anti-Inflammatory herbal composition and method of use |
| EP1417211B1 (en) | 2001-07-27 | 2007-05-30 | Neptune Technologies & Bioressources Inc. | Natural phospholipids of marine origin containing flavonoids and polyunsaturated phospholipids and their uses |
| US7396546B2 (en) * | 2001-08-06 | 2008-07-08 | The Quigley Corporation | Anti-microbial compositions and methods of using same |
| US6956122B2 (en) * | 2001-09-05 | 2005-10-18 | Council Of Scientific & Industrial Research | Multiple fluorescent natural dye compound from a marine organism |
| US20050143463A1 (en) * | 2002-05-03 | 2005-06-30 | The Queen Elizabeth Hospital Research Foundation Inc. | Method of inhibiting angiogenesis |
| US7496497B2 (en) | 2003-12-18 | 2009-02-24 | Taiwan Semiconductor Manufacturing Co., Ltd. | Method and system for selecting web site home page by extracting site language cookie stored in an access device to identify directional information item |
| WO2005120185A2 (en) * | 2004-06-14 | 2005-12-22 | Pacific Institute Of Bioorganic Chemistry, Far-Eastern Branch, Russian Academy Of Sciences (Piboc) | Process for isolating sea cucumber saponin frondoside a, and immunomodulatory methods of use |
| WO2006053184A2 (en) * | 2004-11-10 | 2006-05-18 | The Trustees Of Columbia University In The City Of New York | Methods for treating or preventing a vascular disease |
| JP2006008718A (ja) * | 2005-06-03 | 2006-01-12 | Yamaha Motor Co Ltd | シクロオキシゲナーゼ活性阻害剤 |
| JP2006008719A (ja) * | 2005-06-23 | 2006-01-12 | Yamaha Motor Co Ltd | 血中過酸化脂質抑制剤 |
| WO2007005349A2 (en) * | 2005-06-29 | 2007-01-11 | Coastside Bio Resources | Improved method of processing sea cucumbers, with new compositions of matter |
| RU2323765C2 (ru) * | 2006-01-10 | 2008-05-10 | Государственное образовательное учреждение высшего профессионального образования "Самарский государственный университет" | Способ получения экстрактов из растительного сырья |
| AU2007234746B2 (en) * | 2006-04-07 | 2009-10-01 | Sunten Phytotech Co., Ltd. | Naphthalenedione compounds |
| KR100755728B1 (ko) * | 2007-01-30 | 2007-09-06 | 이영국 | 천식 개선을 위한 건강식품 조성물 및 그 제조방법 |
| KR100914519B1 (ko) * | 2007-06-28 | 2009-09-02 | 동아대학교 산학협력단 | Ｔｈｅｌｅｎｏｔａ ａｎａｘ 유래 스티초포사이드를 유효성분으로 함유하는 항암 조성물 |
| DE102007033907A1 (de) * | 2007-07-20 | 2009-01-22 | Uhde High Pressure Technologies Gmbh | Naturstoffextraktion |
| US7790036B2 (en) * | 2007-10-16 | 2010-09-07 | Yulex Corporation | Rapid expanded solvent extraction |
| KR100974433B1 (ko) * | 2008-02-20 | 2010-08-05 | 강릉원주대학교산학협력단 | 해삼의 건조분말 또는 추출물을 유효성분으로 함유하는당뇨병의 예방 및 치료용 조성물 |
| EP2296675A4 (en) | 2008-05-09 | 2012-07-18 | Rival S E C | ECHINODERM EXTRACTS, MANUFACTURING METHODS AND ITS USES |
| US20090325474A1 (en) * | 2008-06-30 | 2009-12-31 | Batson Chester L | Method and apparatus for processing sea cucumbers |
| KR101166677B1 (ko) | 2008-10-31 | 2012-07-19 | 제주특별자치도 | 항염증제 조성물 및 항암제 조성물 |
| RU2415863C1 (ru) * | 2009-10-12 | 2011-04-10 | Учреждение Российской академии наук Тихоокеанский институт биоорганической химии Дальневосточного отделения РАН (ТИБОХ ДВО РАН) | Средство, стимулирующее клеточный иммунитет млекопитающих |
| JP5827625B2 (ja) | 2009-10-29 | 2015-12-02 | アカスティ ファーマ インコーポレイテッド | 濃縮治療用リン脂質組成物 |
| KR101280431B1 (ko) * | 2010-09-30 | 2013-06-28 | 재단법인 제주테크노파크 | 홍해삼 추출물을 이용한 항알러지제 조성물 및 항균제 조성물 |
| JP6027978B2 (ja) | 2010-12-23 | 2016-11-16 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 関節炎および関節炎に関連する炎症を治療するためのペットフード組成物および方法 |
| KR101217769B1 (ko) * | 2011-12-02 | 2013-01-02 | 제주특별자치도 | 항염증제 조성물 및 항암제 조성물 |
| CA2793322A1 (en) | 2012-10-25 | 2014-04-25 | Ocean Leader Fisheries Limited | Method for extracting oil from sea cucumber material |
| KR101401740B1 (ko) * | 2012-10-29 | 2014-05-30 | 재단법인 전남생물산업진흥원 | 해삼 추출물을 함유하는 전립선 비대증 예방을 위한 기능성 식이조성물 |
| GB2511086A (en) * | 2013-02-22 | 2014-08-27 | Shayonano Singapore Pte Ltd | Process For The Isolation of Carotenoids |
| US9826757B2 (en) | 2013-03-15 | 2017-11-28 | Advance International Inc. | Automated method and system for recovering protein powder meal, pure omega 3 oil and purified distilled water from animal tissue |
| CA2920789C (en) | 2015-06-04 | 2021-05-18 | Advance International, Inc. | Improved methods and systems for recovering protein powder and natural omega-3 oil from animal tissue |
| CN105105118B (zh) * | 2015-09-01 | 2017-09-01 | 大连工业大学 | 一种富含epa海参肠脂质的制备方法 |
| KR101808615B1 (ko) * | 2016-06-28 | 2017-12-13 | 부산대학교 산학협력단 | 해삼 추출물을 유효성분으로 포함하는 알레르기성 호흡기 질환의 예방 또는 치료용 조성물 |
| KR101895150B1 (ko) * | 2017-01-19 | 2018-09-05 | 수산업협동조합중앙회 | 해삼 가수분해물을 포함하는 화장료 조성물 |
| CN108523029A (zh) * | 2017-12-15 | 2018-09-14 | 华南理工大学 | 一种含有叶瓜参提取物的具有延缓衰老功能的组合物及其应用 |
| KR102154596B1 (ko) * | 2018-07-04 | 2020-09-10 | 경상대학교산학협력단 | 해삼 자숙액으로 부터 천식 개선물질의 분리방법 |
| RU2708157C1 (ru) * | 2019-01-11 | 2019-12-04 | Федеральное государственное автономное образовательное учреждение высшего образования "Дальневосточный федеральный университет" (ДВФУ) | Способ получения каротиноидов из гидробионтов |
| CN111808673A (zh) * | 2020-07-09 | 2020-10-23 | 江苏海宏制药有限公司 | 一种海参油的亚临界流体萃取工艺 |
| RU2755312C1 (ru) * | 2021-02-09 | 2021-09-15 | Андрей Федорович Беговатов | Биологически активная добавка из голотурии и способ её получения |
| KR20250108848A (ko) * | 2024-01-09 | 2025-07-16 | 국립부경대학교 산학협력단 | 해삼 유래 세포외소포를 포함하는 아토피 예방 및 치료용 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57212200A (en) * | 1981-06-23 | 1982-12-27 | Takeda Chem Ind Ltd | Preparation of echinoside a |
| JPH01316344A (ja) * | 1988-03-23 | 1989-12-21 | Yoshitomi Pharmaceut Ind Ltd | 色素物質の除去法 |
| SU1573578A1 (ru) * | 1988-05-04 | 1996-03-27 | Владивостокский государственный медицинский институт | Способ выделения аллергена из биологического сырья |
| JPH05155736A (ja) * | 1991-12-10 | 1993-06-22 | Nakano Seiyaku Kk | 化粧料 |
| JPH06287111A (ja) * | 1991-12-24 | 1994-10-11 | Takeshi Mihara | 毛髪生長促進化粧料 |
| US5214062A (en) * | 1992-04-08 | 1993-05-25 | Clintec Nutrition Co. | Method and composition for treating immune disorders, inflammation and chronic infections |
| JPH07316584A (ja) * | 1994-05-25 | 1995-12-05 | Shimadzu Corp | 高度不飽和脂肪酸の精製方法 |
| RU2112527C1 (ru) * | 1995-07-06 | 1998-06-10 | Полярный научно-исследовательский институт морского рыбного хозяйства и океанографии им.Н.М.Книповича | Способ получения комплекса биологически активных продуктов из голотурии |
| US5770205A (en) * | 1996-08-05 | 1998-06-23 | Coastside Bio Resources | Tissue fractions of sea cucumber for the treatment of inflammation |
-
1998
- 1998-01-21 US US09/010,123 patent/US6055936A/en not_active Expired - Lifetime
-
1999
- 1999-01-20 WO PCT/US1999/001179 patent/WO1999037314A1/en not_active Ceased
- 1999-01-20 EP EP99903215A patent/EP1047437A4/en not_active Withdrawn
- 1999-01-20 IL IL13729399A patent/IL137293A0/xx unknown
- 1999-01-20 NZ NZ506420A patent/NZ506420A/en unknown
- 1999-01-20 AU AU23290/99A patent/AU737567B2/en not_active Ceased
- 1999-01-20 RU RU2000117774/15A patent/RU2234928C2/ru not_active IP Right Cessation
- 1999-01-20 BR BR9907189-4A patent/BR9907189A/pt not_active IP Right Cessation
- 1999-01-20 CN CNB99802306XA patent/CN1247205C/zh not_active Expired - Fee Related
- 1999-01-20 JP JP2000528296A patent/JP2002501030A/ja active Pending
- 1999-01-20 KR KR1020007008003A patent/KR100573423B1/ko not_active Expired - Fee Related
- 1999-01-20 CA CA2319093A patent/CA2319093C/en not_active Expired - Fee Related
-
2000
- 2000-07-07 NO NO20003535A patent/NO327883B1/no not_active IP Right Cessation
- 2000-07-20 IS IS5566A patent/IS5566A/is unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002501030A5 (enExample) | ||
| CA2319093A1 (en) | Sea cucumber carotenoid lipid fraction products and methods of use | |
| US6399105B1 (en) | Sea cucumber carotenoid lipid fraction products and methods of use | |
| Ebrahimi et al. | Persian walnut composition and its importance in human health | |
| CN101686725A (zh) | 消炎和抗氧化协同作用的膳食补充组合物 | |
| CN101616681A (zh) | 包含竹子和黄芩的提取物的用于治疗特应性皮炎的组合物 | |
| US20040166182A1 (en) | Modification of cyclooxygenase and lipoxygenase activity with asteridae extracts and optionally boswellic acid | |
| JPH09278662A (ja) | 抗アレルギー剤 | |
| JP4979184B2 (ja) | 杜仲葉水抽出成分を含むリパーゼ阻害剤 | |
| JP2018168144A (ja) | リパーゼ阻害剤、及びその利用 | |
| EP2445859B1 (en) | Method for isolating cimiracemate a | |
| WO2021261341A1 (ja) | ホスホジエステラーゼ５活性阻害または勃起機能改善用組成物 | |
| JP5122924B2 (ja) | 抗肥満剤 | |
| JP2000290189A (ja) | 抗アレルギー剤 | |
| CN106163535A (zh) | 包含胡桃萃取物的抗肥胖剂 | |
| JP2018168076A (ja) | リパーゼ阻害剤 | |
| JP2008169172A (ja) | 炎症性サイトカイン産生抑制作用を有するノルセファラジオンｂ誘導体、それからなる食品製剤、化粧品、抗炎症剤 | |
| JP2004292368A (ja) | 抗肥満剤 | |
| WO2021200275A1 (ja) | 経口組成物及びえぐ味改善方法 | |
| HK1169380B (en) | Method for isolating cimiracemate a | |
| KR20200020354A (ko) | 필레아 마티니 추출물을 포함하는 염증성 질환 예방 또는 치료용 조성물 | |
| JPH05271057A (ja) | リウマチ改善治療剤 |